F
Fiona Bonar
Publications - 10
Citations - 1122
Fiona Bonar is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 2 publications receiving 1036 citations.
Papers
More filters
Journal ArticleDOI
Histopathology of common tendinopathies. Update and implications for clinical management.
TL;DR: The histopathological findings in athletes with overuse tendinopathies are consistent with those in tendinosis — a degenerative condition of unknown aetiology, which may have implications for the prognosis and timing of a return to sport after experiencing tendon symptoms.
Journal ArticleDOI
Overuse tendinosis, not tendinitis part 1: a new paradigm for a difficult clinical problem.
TL;DR: If physicians acknowledge that overuse tendinopathies are due to tendinosis, as distinct from tendinitis, they must modify patient management in at least eight areas.
Journal ArticleDOI
High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma
Raphael Koch,Hans Gelderblom,Lianne M. Haveman,Bénédicte Brichard,Heribert Jürgens,Sona Cyprova,H. M. Van Den Berg,Wolf A Hassenpflug,Anna Raciborska,Torben Ek,Daniel Baumhoer,Gerlinde Egerer,Hans Theodor Eich,Marleen Renard,Peter Hauser,Stefan Burdach,Judith V.M.G. Bovée,Fiona Bonar,Peter Reichardt,Jarmila Kruseova,Jendrik Hardes,Thomas Kühne,Torsten Kessler,Stéphane Collaud,Marie Bernkopf,Trude Butterfass-Bahloul,Catharina Dhooge,Sebastian Bauer,János Kiss,Michael Paulussen,Angela Hong,Andreas Ranft,Beate Timmermann,Jelena Rascon,Volker Vieth,Jukka Kanerva,Andreas Faldum,Markus Metzler,Wolfgang Hartmann,Lars Hjorth,Vivek A Bhadri,Uta Dirksen +41 more
TL;DR: In patients with very high-risk EWS, additional TreoMel-HDT was of no benefit for the entire cohort of patients and high-dose chtx was of benefit in children children <14y with metastatic Ewing-sarcoma and may be of benefit for children age < 14 years.
Journal ArticleDOI
Systemic treatments and outcomes in CIC ‐rearranged Sarcoma: A national multi‐centre clinicopathological series and literature review
Elizabeth Connolly,Vivek A Bhadri,J. Wake,Katrina M. Ingley,Jeremy Lewin,Susie Bae,Daniel D. Wong,Anne P Long,David Pryor,Stephen P. Thompson,Madeleine Strach,Peter Grimison,Annabelle Mahar,Fiona Bonar,Fiona Maclean,Angela Hong +15 more
TL;DR: The aim of this work was to further characterise clinical features of CIC‐rearranged sarcomas and explore clinical management including systemic treatments and outcomes.
Journal ArticleDOI
Immunohistochemistry for FOSB and FOS is a Useful Ancillary Tool in the Diagnosis of Epithelioid Hemangioma but There are Pitfalls in Interpretation Including Expression in Other Vascular Lesions
Kwan Yee Tsui,Fiona Maclean,D.H. Moir,Alison L. Cheah,Fiona Bonar,J. T. Tabot,Anthony J. Gill,Ana Cristina Vargas +7 more
TL;DR: This study presents the largest cohort of epithelioid hemangiomas assessed with both FOS and FOSB and demonstrated that the use of both antibodies increases the detection rate of these proliferations by 10%.